Caggiano, Anthony,Ganguly, Anindita,Iaci, Jennifer,Parry, Tom
申请号：
AU2009292216
公开号：
AU2009292216B2
申请日:
2009.07.17
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
